ArticleClinical pharmacology and therapeutics2022

The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung Cancer.

Nikki de Rouw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.